Cochlear Limited

Cisco Technology, Inc.

John Michael Heasman

Stefan Jozef Mauger

Peter Gibson

Adam A Hersbach

Stephen John O'Leary

Luke Campbell

Pam W Dawson

Sean Lineaweaver

Kerrie Plant

Kieran Reed

Paul Michael Carter

Stephen Fung

Alex Von Brasch

Martin E G Hillbratt

Jan Raymond Janssen

Torsten Lehmann

Ryan Orin Melman

Nicholas Charles Pawsey

Richard Bruce Murphy

Riaan Rottier

Bill Metzenthen

Mary-Beth Brinson

Christofer William Bester

Stephen O'leary

Kristien Johanna Maria Verhoeven

Presented herein are techniques that make use of objective measurements obtained in response to acoustic stimulation signals. More specifically, at least one measure of outer hair cell function and at least one measure of auditory nerve function are obtained from a tonotopic region of an inner ear of a recipient of a hearing prosthesis. The at least one measure of auditory nerve function and the least one measure of outer hair cell function are then analyzed relative to one another.

Objective determination of acoustic prescriptions

A method for processing sound that includes, generating one or more noise component estimates relating to an electrical representation of the sound and generating an associated confidence measure for the one or more noise component estimates. The method further comprises processing based on the confidence measure, the sound.

Sound processing with increased noise suppression

Presented herein are techniques for monitoring the insertion of an intra-cochlear stimulating assembly for the occurrence of one or more insertion stop conditions. The insertion stop conditions are detectable events indicating that movement of the stimulating assembly into a recipient's cochlea should be at least temporarily stopped. The insertion monitoring is based on objectively measured inner ear potentials, such as acoustically-evoked potentials.

Monitoring stimulating assembly insertion

Presented herein are techniques for clinical-based automated control of the delivery of treatment substances to at least one inner ear of a recipient of an implantable medical device. More specifically, in-vivo biomarkers are analyzed to determine a biological state/status of one or more physiological elements of the inner ear. Subsequent delivery of one or more treatment substances to the inner ear of the recipient are controlled based on the determined biological state of the one or more physiological elements of the inner ear.

Clinical-based automated delivery of treatment substances to the inner ear

A method for processing sound that includes, generating one or more noise component estimates relating to an electrical representation of the sound and generating an associated confidence measure for the one or more noise component estimates. The method further comprises processing, based on the confidence measure, the sound.

A method, including the action of operating a sense prosthesis, such as a retinal implant, according to a first operating regime while the recipient has a first fatigue level, and operating the sense prosthesis according to a second operating regime while the recipient has a second fatigue level that is greater than the first fatigue level.

Shifting of output in a sense prosthesis

A method, including energizing one or more electrodes of a cochlear electrode array to induce a current flow in the cochlea at a plurality of temporal locations, measuring one or more electrical properties at one or more locations in the cochlea resulting from the induced current flow at the plurality of different temporal locations and determining whether or not trauma has occurred based on a change between the measured electrical properties from the first temporal location to the second temporal location.

Electrical techniques for biomarker detection in a cochlea

Presented herein are techniques that enable electroporation of the cells of a recipient of a tissue-stimulating prostheses while the tissue-stimulating prosthesis is implanted in the recipient. Tissue-stimulating prostheses in accordance with embodiments presented herein are configured such that the stimulation electronics (e.g., current sources and integrated circuit) of the prosthesis are not exposed to the high voltages used in electroporation.

Medical electroporation

A body worn or implantable hearing prosthesis, including a device configured to capture an audio environment of a recipient and evoke a hearing percept based at least in part on the captured audio environment, wherein the hearing prosthesis is configured to identify, based on the captured audio environment, one or more biomarkers present in the audio environment indicative of the recipient's ability to hear.

Utilization of vocal acoustic biomarkers for assistive listening device utilization

An electrode array insertion tool, including an assembly configured to provide direct array insertion functionality and ancillary array insertion functionality to a user thereof. In an exemplary embodiment, the tool includes an extra-cochlea bone conduction actuator system, and the ancillary array insertion functionality is output of vibrations directly to the cochlea by the system.

Electrode insertion tool with additional functionality

A method, including obtaining hearing data and speech data for a statistically significant number of individuals, and analyzing the obtained hearing data and speech data using a neural network to develop a predictive algorithm for hearing loss based on the results of the analysis, wherein the predictive algorithm predicts hearing loss based on input indicative of speech of a hearing impaired person who is not one of the individuals.

Growing community of inventors

Hampton, Australia

John Michael Heasman